A vaccine developed to prevent tuberculosis, now also used to treat bladder cancer, reduced the incidence of Alzheimer’s disease four-fold.
“BCG also increases anti-inflammatory cytokines in the brain, thereby reducing neuroinflammation. The new study involved 1,371 patients (average age, 68 years) with bladder cancer who received various agents as intravesical chemotherapy.”